Cargando…

Identifying unmet clinical need in hypertrophic cardiomyopathy using national electronic health records

INTRODUCTION: To evaluate unmet clinical need in unselected hypertrophic cardiomyopathy (HCM) patients to determine the risk of a wide range of subsequent cardiovascular disease endpoints and safety endpoints relevant for trial design. METHODS: Population based cohort (CALIBER, linked primary care,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pujades-Rodriguez, Mar, Guttmann, Oliver P., Gonzalez-Izquierdo, Arturo, Duyx, Bram, O’Mahony, Constantinos, Elliott, Perry, Hemingway, Harry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764451/ https://www.ncbi.nlm.nih.gov/pubmed/29324812 http://dx.doi.org/10.1371/journal.pone.0191214

Ejemplares similares

Rheumatoid Arthritis and Incidence of Twelve Initial Presentations of Cardiovascular Disease: A Population Record-Linkage Cohort Study in England
por: Pujades-Rodriguez, Mar, et al.
Publicado: (2016)

Novel genotype–phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy
por: Lopes, Luis R, et al.
Publicado: (2015)

Prediction of thrombo‐embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk‐CVA)
por: Guttmann, Oliver P., et al.
Publicado: (2015)

Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases
por: Pujades-Rodriguez, Mar, et al.
Publicado: (2016)

The genetics of hypertrophic cardiomyopathy
por: Akhtar, Mohammed, et al.
Publicado: (2018)

Time spent at blood pressure target and the risk of death and cardiovascular diseases
por: Chung, Sheng-Chia, et al.
Publicado: (2018)

The diagnosis, burden and prognosis of dementia: A record-linkage cohort study in England
por: Pujades-Rodriguez, Mar, et al.
Publicado: (2018)

Correction: The diagnosis, burden and prognosis of dementia: A record-linkage cohort study in England
por: Pujades-Rodriguez, Mar, et al.
Publicado: (2018)

Auditing the safety and efficacy of interventional septal reduction therapies in hypertrophic obstructive cardiomyopathy at a specialized tertiary centre
por: Sorbini, M, et al.
Publicado: (2023)

Hypertrophic cardiomyopathy: The need for randomized trials
por: Olivotto, Iacopo, et al.
Publicado: (2013)

Is This the Prime Time for Transradial Access Left Ventricular Endomyocardial Biopsy?
por: Tyler, Zaccharie, et al.
Publicado: (2021)

Heart Rate Recovery in Patients With Hypertrophic Cardiomyopathy
por: Patel, Vimal, et al.
Publicado: (2014)

Prevalence of Hypertrophic Cardiomyopathy in the UK Biobank Population
por: Lopes, Luis R., et al.
Publicado: (2021)

Metformin use and cardiovascular outcomes after acute myocardial infarction in patients with type 2 diabetes: a cohort study
por: Bromage, Daniel I., et al.
Publicado: (2019)

Hypertrophic cardiomyopathy: a heart in need of an energy bar?
por: Vakrou, Styliani, et al.
Publicado: (2014)

The embryological basis of subclinical hypertrophic cardiomyopathy
por: Captur, Gabriella, et al.
Publicado: (2016)

Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy
por: Braunwald, Eugene, et al.
Publicado: (2023)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers
por: Lorenzini, Massimiliano, et al.
Publicado: (2020)

Ethnicity and the first diagnosis of a wide range of cardiovascular diseases: Associations in a linked electronic health record cohort of 1 million patients
por: George, Julie, et al.
Publicado: (2017)

Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing
por: Lopes, Luis R, et al.
Publicado: (2013)

The use of multiparametric CMR to predict impaired exercise capacity in hypertrophic cardiomyopathy
por: Flett, Andrew S, et al.
Publicado: (2009)

Myocardial Perfusion Defects in Hypertrophic Cardiomyopathy Mutation Carriers
por: Hughes, Rebecca K., et al.
Publicado: (2021)

The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy
por: Kittleson, Mark D, et al.
Publicado: (2021)

An unmet need: arrhythmia detection by implantable loop recorder in the systemic right ventricle
por: Kakarla, Jayant, et al.
Publicado: (2023)

Hypertrophic Obstructive Cardiomyopathy
por: Cohen, Lawrence S.
Publicado: (1972)

Disopyramide for Hypertrophic Cardiomyopathy
por: Sanchez-Nadales, Alejandro, et al.
Publicado: (2019)

Unmet needs in asthma
por: Gruffydd-Jones, Kevin
Publicado: (2019)

Left ventricular strain and untwist in hypertrophic cardiomyopathy: Relation to exercise capacity
por: Abozguia, Khalid, et al.
Publicado: (2010)

Novel Therapies to Address Unmet Needs in ITP
por: Mingot-Castellano, María Eva, et al.
Publicado: (2022)

Mitral Subvalvular Apparatus Intervention In Patients With Obstructive Hypertrophic Cardiomyopathy: does it need?
por: Bogachev-Prokophiev, A, et al.
Publicado: (2015)

Characteristics and Outcomes of Elderly Patients With Hypertrophic Cardiomyopathy
por: Alashi, Alaa, et al.
Publicado: (2021)

Hypertrophic Cardiomyopathy in Elderly Individuals: Is It a Rose by Another Name?
por: Lee, Deacon Z. J., et al.
Publicado: (2021)

An Unusual Type of Hypertrophic Cardiomyopathy
por: Seo, Hye-Sun, et al.
Publicado: (2009)

Recent advances in hypertrophic cardiomyopathy
por: Yingchoncharoen, Teerapat, et al.
Publicado: (2014)

Diagnosis and management of hypertrophic cardiomyopathy
por: Pantazis, Antonis, et al.
Publicado: (2015)

Hypertrophic Cardiomyopathy: A Review
por: Houston, Brian A, et al.
Publicado: (2015)

Aortic biomechanics in hypertrophic cardiomyopathy
por: Badran, Hala Mahfouz, et al.
Publicado: (2015)

Ranolazine for Angina in Hypertrophic Cardiomyopathy
por: Amin, Akhtar, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ih8gftbd9j8ptebu5l2cqc8cc2